Navigation Links
Inflammatory in Biological Technology

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... hematopoietic cell transplantation. GVHD is an inflammatory disease initiated by T cells in the donor graft ... is mediated by a variety of effector cells and inflammatory cytokines. GVHD presents in both acute and ... Similar to acute GVHD, there is also an inflammatory condition of the GI tract associated with cGVHD. ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... Europe of SIMPONI, a novel biologic treatment for inflammatory diseases. In our industry, long-term strength ... (golimumab), a subcutaneous treatment for certain inflammatory diseases; SAPHRIS (asenapine), for the acute ... market growth. REMICADE is a treatment for inflammatory diseases that Schering-Plough markets in ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... an alternative method for treatment of pulmonary inflammatory disease, that is, the delivery of a potent ... novel pulmonary delivery system in patients with inflammatory lung diseases will be of interest." "The ... applications of oral BDP in a number of pulmonary inflammatory disorders, such as asthma or interstitial lung ...

Knocking the Wind Out of Asthmatics: Help from Hippocrates

... as a way to safely and effectively avoid chronic inflammatory and allergy like problems, like asthma, perennial ... that interfere with weight loss, and other inflammatory conditions such as arthritis and migraine, ... reactions to over 300 foods and chemicals. These inflammatory reactions are linked to chronic health problems ...

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

... to the new position of director, immunology and inflammatory diseases, effective immediately. Dr. Laroux ... important in gastro-intestinal diseases, such as inflammatory bowel disease (IBD). Dr. Laroux's current study ... and treat a wide range of human disorders -- from inflammatory disease to cancer -- based on the company's ...

UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows

... four recipients of the 2009 Research Awards in inflammatory Bowel Disease (IBD) for Gastroenterology (GI) ... better patient care." The Research Awards in inflammatory Bowel Disease for GI Fellows was established in ... programs to people on the front lines of treating inflammatory bowel disease," said Olav Hellebo, UCB's ...

Resverlogix's Success in Inflammation Program Results in 2 Patents Filed

... research and development (R&D) program for inflammatory diseases. Two new patent applications have been ... for novel compounds and their use in regulating inflammatory markers. inflammatory markers are proteins generated by the body during ...

ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

... inappropriate immune system response underlying inflammatory bowel diseases by blocking the CCR9 chemokine ... for the treatment of Crohn's disease and other inflammatory disorders of the gastrointestinal system. DDW ... Clinical Trials - Immunology, Microbiology & inflammatory Bowel Disease Location: McCormick Place, ...

Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing

... preventative approaches to autoimmune and inflammatory diseases, today announced that Roche Venture Fund ... advancement of Opsona's clinical trials targeting inflammatory diseases such as rheumatoid arthritis, lupus and ... for in-licensing aimed at treating autoimmune and inflammatory diseases. Commenting on the announcement, ...

ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist

... to specifically target the C5a receptor, a potent inflammatory mediator and component of the complement system, ... It adds another promising approach to addressing inflammatory and autoimmune diseases to ChemoCentryx's ... a set of proteins that regulate certain types of inflammatory responses by the immune system. Fragments of ...

Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist

... drug candidate for the treatment and control of inflammatory and allergic diseases linked to the arachidonic ... Development. "We may also explore AM211 in other inflammatory diseases based on the safety and proof of ... and early development of compounds to treat inflammatory disease linked to the phospholipid pathways. ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... Arthritis Psoriatic arthritis is a chronic inflammatory arthropathy manifesting with joint pain and ... form of spinal arthritis, and symptoms of inflammatory back pain often first present in people under the ... arthritis, ankylosing spondylitis is a systemic inflammatory disease that, in addition to its effect on the ...

Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)

... establish category leadership in autoimmune and inflammatory disease markets." About Trubion Trubion ... product candidates to treat autoimmune and inflammatory diseases and cancer. The company's mission is to ... such as TRU-015 and SBI-087 for autoimmune and inflammatory diseases, developed under the company's Wyeth ...

Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis

... another disorder of the digestive tract, are inflammatory bowel diseases that affect more than one million ... life will help inspire people living with inflammatory bowel diseases to join the fight in raising ... About Ulcerative Colitis (UC) UC, a chronic inflammatory bowel disease affecting nearly 500,000 people in ...

Opsona Therapeutics Closes EUR18M Funding

... and preventative approaches to autoimmune and inflammatory diseases, today announced the completion of an ... advancement of Opsona's clinical trials targeting inflammatory diseases, such as rheumatoid arthritis, lupus ... proof of concept studies in patients by targeting inflammatory diseases through the innate immune system, with ...

Frost & Sullivan Recognizes ESBATech's Innovation in Developing Antibody Fragments for Biologic Therapeutics

... that has been identified as the cause of many inflammatory conditions including uveitis, a group of inflammatory diseases affecting the uvea. To date, the only ... for several indications including uveitis, an inflammatory condition responsible for an estimated 10 to 15 ...

Axikin Pharmaceuticals Spins out of Actimis

... small molecule therapeutics for respiratory and inflammatory diseases, today announced a $3 million private ... molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory ...

Cequent Names Ted Hibben Chief Business Officer

... activities in three major areas. On our inflammatory bowel disease (IBD) program, he will look for ... and treat a wide range of human disorders - from inflammatory disease to cancer - based on the company's ... candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful ...

Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice

... the treatment of a variety of chronic and acute inflammatory diseases," said Jay Lichter, Ph.D., CEO of ... our work into pre-clinical studies in other inflammatory disease models," said Josh Schultz, Ph.D., ... exploration of chemokine interactions involved in inflammatory signaling." In addition to targeting ...

Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers

... such as gastrointestinal (GI) injury, inflammatory bowel disease, and bone disease," said Dr. Ted W. ... or cancer chemotherapy induced GI injury, inflammatory bowel disease, and bone disease. About ... therapy-induced mucositis and inflammatory bowel disease. In addition, Nuvelo is pursuing ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... -- Data presented this week by UCB at Advances in inflammatory Bowel Diseases 2008, the Crohn's & Colitis ... life measurements was assessed by the 32-question inflammatory Bowel Disease Questionnaire (IBDQ), which ... with ulcerative colitis, Crohn's disease is an inflammatory bowel disease (IBD). About CIMZIA (R) ...

Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 American Society of Hematology (ASH) Meeting

... significant advances in cardiovascular disease, inflammatory disease and cancer, today announced that data ... intends to explore their potential in other inflammatory diseases and cancers. Portola is developing its ... over current treatments for cardiovascular and inflammatory diseases and cancer. Portola's two lead Phase ...

Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients

... correlates nicely with the nasal lavage inflammatory marker data," said Morria president, Yuval Cohen. ... results regarding MRX-4 modulating the levels of inflammatory mediators (IL-5, IL-13, MCP-1, TNF-alpha and ... thereby protecting the cell against inflammatory agents. Morria is determined to become a ...

Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

... as well as its pre-clinical progress in asthma, inflammatory bowel disease, ophthalmology and cystic fibrosis. ... the treatment of a variety of acute and chronic inflammatory conditions including respiratory, skin, airway and gastro-intestinal inflammatory diseases. For more information please visit ...

Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium

... and Asian populations relative to inflammatory response and cardiovascular disease. Dr. ... Disease Coronary artery disease (CAD) is an inflammatory disease in which plaque builds up inside the ... nutritional compounds for their effects on inflammatory responses and other genetic variations, given ...

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology

... researchers will present eight posters from its inflammatory disease program at the Annual Meeting of the ... - CXCL13 is a molecule that recruits B cells into inflammatory cell aggregates called follicles. In ... the joint promoting the generation of new inflammatory follicles and contributing to the disease ....

New Company to Develop Nutritional Interventions Against Chronic Inflammatory and Infectious Diseases

... develop nutritional interventions against chronic inflammatory and infectious diseases. BioTherapeutics Inc. ... in mouse studies and is linked to chronic inflammatory or infectious disease prevention or treatment. ... and therapeutic interventions against chronic inflammatory and infectious diseases. BioTherapeutics Inc. ...

ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development

... of Crohn's disease, ulcerative colitis and other inflammatory disorders of the gastrointestinal system. This ... known to play a pivotal role in the migration of inflammatory T cells to the digestive tract, resulting in the ... systems in order to treat autoimmune diseases, inflammatory disorders and cancer. The chemokine system is a ...

Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds

... agent. The assay measures key inflammatory mediators, which are released by the ... significantly reduced the levels of the following inflammatory mediators: GM-CSF (Granulocyte ... Necrosis Factor alpha), MIP-1 alpha (Macrophage inflammatory Protein 1 alpha), MCP-1 (Monocyte Chemoattractant ...

Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.

... familial polyposis, human papilloma virus, and inflammatory bowel disease, and their input will be paramount ... and treat a wide range of human disorders - from inflammatory disease to cancer - based on the company's ... targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful ...

Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting

... Abstract Title: MEK Inhibitor RDEA119 Suppresses inflammatory Cytokine Production Induced by ... a precursor to trials in patients with inflammatory diseases. Lastly, we have evaluated our ... MEK inhibitor for the treatment of cancer and inflammatory diseases, RDEA436, in a human ...

Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo

... simultaneously as potential therapeutics for inflammatory bowel disease. Our milestone goal, which we ... and treat a wide range of human diseases -- from inflammatory diseases to cancer -- based on the company's ... targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful ...

GlaxoSmithKline and Cellzome Announce Major Strategic Alliance

... of Drug Candidates for inflammatory Diseases LONDON and CAMBRIDGE, England and ... new generation of kinase-targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule ... small-molecule kinase inhibitors targeting key inflammatory mediators such as PI3Kg and d, Zap-70, Jak3 ...

Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing

... are responsible for initiating and maintaining inflammatory diseases, announced today that the company has ... to yield new high value therapeutics against inflammatory and autoimmune disease." Osprey Pharmaceuticals ... receptor axis, which play a significant role in inflammatory kidney diseases and other autoimmune ...

Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award

... of small molecules that specifically target inflammatory disorders. Moreover, the company has several ... new family of anti-inflammatory drugs for chronic inflammatory diseases, such as Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis and inflammatory Bowel Disease. VBL has also developed the ...

ViroPharma To Acquire Lev Pharmaceuticals

... therapeutic products for the treatment of inflammatory diseases, for $442.9 million of ... is also implicated in a number of other serious inflammatory disorders. Hereditary angioedema, or C1-INH deficiency, is a dangerous and potentially deadly inflammatory disease affecting up to 10,000 patients in the ...

Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout

... -- Dr. Fernando Perez-Ruiz Joins Ardea's inflammatory Disease Scientific ... from gout, which is the most common form of inflammatory arthritis in men over 40. Gout, also known as ... for the treatment of HIV, cancer and inflammatory diseases, including gout. We have four drug ...

Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology

... activation, proliferation and the production of inflammatory mediators. Suppression of the ERK pathway ... therapeutic approach for treating chronic inflammatory diseases such as rheumatoid arthritis. RDEA119 is ... support the development of RDEA119 in inflammatory diseases, we are currently conducting a Phase 1 ...

Amira Pharmaceuticals Hires Industry Veteran for CFO Position

... discovery and development of compounds to treat inflammatory diseases, announced the hiring of Michael V. ... and early development of compounds to treat inflammatory disease linked to the eicosanoid pathway. Amira ... with GlaxoSmithKline and Roche in the area of inflammatory disease. Amira combines the rigor of a big ...

Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program

... inhibits NF-kappa B, a protein implicated in the inflammatory cascade in diseases such as inflammatory bowel ... of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis." ... been evaluated for safety, tolerability and anti- inflammatory drug effect in an exploratory, dose-ranging US ...
Other Contents
(Date:4/15/2014)... Biologists at UC San Diego have succeeded in ... hormone responsible for growth and resistance to drought. ... studies to determine how the hormone helps plants ... by the continuing increase in the atmosphere,s carbon ... achievement appears in the April 15 issue of ...
(Date:4/15/2014)... Looking at the question of how social behavior has ... universities in Mainz and Basel have gained new insights ... simply compete for food. Rather the siblings share what ... absent," explained Dr. Jol Meunier of the Evolutionary Biology ... University of Mainz (JGU). The team of biologists from ...
(Date:4/15/2014)... (April 15, 2014) The American Association of Anatomists ... All awards will be presented during the Closing ... Hotel on Tuesday, April 29th at 7:30 p.m. during ... , The 2014 award winners are: , ... PhD, of the Icahn School of Medicine at Mount ...
Breaking Biology News(10 mins):Biologists develop nanosensors to visualize movements and distribution of plant hormone 2Sibling cooperation in earwig families gives clues to early evolution of social behavior 2American Association of Anatomists 2014 award winners 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
Other TagsOther Tags